If we’re being honest, there’s a story about hepatitis C that almost no one is telling in Malaysia.
It used to be one of the worst diagnoses in liver medicine. A virus that quietly damaged the liver over decades, eventually causing cirrhosis and liver cancer in many of those infected. Treatment in the 2000s was a 6-to-12-month ordeal of weekly injections and daily pills with brutal side effects, working only about half the time.
That’s not the story anymore.
Sometime around 2014, hepatitis C treatment was completely transformed by a new class of drugs called direct-acting antivirals (DAAs). The treatment is now 8 to 12 weeks of well-tolerated oral pills. Cure rates exceed 95%. Side effects are typically mild. The condition we used to manage for life can now actually be eliminated from the body.
Which brings us to the real problem in 2026: not the disease itself, but the fact that most people who have hepatitis C don’t know it. The cure is sitting on the shelf, waiting. The diagnosis is the bottleneck.
What Hepatitis C Actually Is
Hepatitis C is a viral infection that affects the liver. It’s caused by the hepatitis C virus (HCV), which spreads through blood-to-blood contact. Once in the body, HCV typically establishes a chronic infection — only about 15-25% of new infections clear on their own. The remaining majority become long-term carriers, often without knowing it.
Over years to decades of chronic infection, HCV slowly damages the liver. Inflammation leads to fibrosis (scarring). Fibrosis can progress to cirrhosis (severe scarring with reduced liver function). Cirrhosis can lead to liver failure or liver cancer. The progression is slow — typical timelines are 20-30 years from infection to serious complications — but the damage is real.
The catch: most people feel completely fine through most of this progression. Symptoms typically don’t appear until liver damage is already substantial.
How Hepatitis C Spreads — and Why "Sexual Transmission" Is Complicated
This is where the conversation gets nuanced and worth understanding properly.
The main transmission route: blood-to-blood contact.
Hepatitis C requires direct contact between infected blood and your bloodstream. The most common transmission scenarios globally:
- Sharing injection drug equipment (the most common transmission route in many countries)
- Receiving contaminated blood transfusions or blood products before donor screening became universal (still relevant for older Malaysians who received transfusions before the early 1990s)
- Unsterile medical or dental equipment, particularly in less regulated settings
- Unsterile tattoo or piercing equipment
- Sharing personal items that may carry small amounts of blood (razors, toothbrushes, nail clippers)
- Mother-to-child transmission during birth (less common than hepatitis B)
- Healthcare worker needle-stick injuries
Sexual transmission—the nuanced part.Hepatitis C can be sexually transmitted, but the risk is much lower than for HIV or hepatitis B in most circumstances. Standard heterosexual sex with an infected partner carries low transmission risk per encounter. However, certain practices and circumstances substantially increase the risk:
- Sex during menstruation (where blood contact is more likely)
- Anal sex, particularly without condoms (small mucosal tears can create blood contact)
- Sex with multiple partners
- Co-infection with HIV (HCV transmits much more readily in HIV-positive individuals)
- Rough sex or any practice that causes bleeding
Why hepatitis C testing belongs in sexual health screening.Even though sexual transmission is less efficient than for some other STIs, hepatitis C testing is part of comprehensive STI panels for several reasons. Many people at higher risk for HCV are also at higher risk for HIV and other STIs. Co-infection management matters. And finding hepatitis C means finding a curable condition that can be eliminated before it causes liver damage.
Who Should Get Tested
Current guidelines recommend hepatitis C screening for several groups in addition to STI panel testing:
- Anyone with risk factors like injection drug use history (current or past)
- Recipients of blood transfusions or organ transplants before universal screening was implemented (in Malaysia, this means transfusions before the early 1990s)
- Healthcare workers and others with potential occupational exposure
- People with HIV (co-infection is common)
- Anyone with persistent abnormal liver function tests of unknown cause
- Children of mothers with hepatitis C
- Sexual partners of people with hepatitis C
- People with tattoos or piercings done in unregulated settings
Many countries have moved toward universal one-time hepatitis C screening for all adults regardless of risk factors. The reasoning is simple: testing is cheap, effective treatment exists, and many carriers have no obvious risk factors but still benefit from being identified and cured.
How Testing Works
Hepatitis C testing is a two-step process:
Step 1: Antibody test (anti-HCV).
Detects whether you’ve ever been exposed to hepatitis C. A positive antibody test means your immune system has encountered the virus at some point — but doesn’t tell us whether you currently have active infection.
Step 2: HCV RNA test (viral load).
If antibody is positive, the next step is testing for actual viral RNA — the genetic material of the virus. A positive RNA test confirms current active infection. A negative RNA test (with positive antibody) means you’ve cleared the infection at some point and no longer have it.
Possible outcomes from this two-step approach.
Both negative.
No exposure, no infection. No further action needed.
Antibody positive, RNA negative.
Past exposure that was resolved (either spontaneously cleared or successfully treated). No current infection. No further treatment needed. Note: re-infection is possible, so safe practices still apply.
Both positive.
Current chronic infection. Treatment recommended. This is the scenario where modern treatment delivers cure.
Window period.
Antibodies develop within 4 to 12 weeks of infection. RNA testing can detect infection earlier — within 1 to 2 weeks of exposure. For testing after a known exposure, your doctor will recommend appropriate timing.
The Treatment Revolution
This is the part of hepatitis C that’s genuinely worth getting excited about.
Direct-acting antivirals (DAAs) work directly against the virus.
Modern hepatitis C treatment uses combinations of antiviral drugs that target specific viral proteins. The medications work directly — they don’t depend on stimulating the immune system the way older treatments did. This results in much higher cure rates with much shorter, better-tolerated treatment courses.
Treatment course: typically 8 to 12 weeks of daily pills.
That’s it. A few months of taking pills once a day. No injections. Most regimens are well tolerated, with mild side effects (occasional headache, fatigue, mild nausea) that don’t significantly affect daily life.
Cure rates exceed 95%.
“Cure” in the medical sense means sustained virological response—no detectable virus 12 weeks after completing treatment. For practical purposes, this is a true cure: the virus is gone, doesn’t come back, and the liver can begin healing whatever damage occurred.
Common regimens.
Several different DAA combinations are available — sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and others. Your doctor will choose the regimen based on the genotype of your virus, any prior treatment history, presence of cirrhosis, and other factors. Most regimens work across multiple genotypes, so this part has gotten simpler over the years.
Cost in Malaysia.
DAA medications are increasingly accessible in Malaysia. Treatment courses can be obtained through specialised hepatology services and government programs. Some patients access treatment through subsidy programs that have made DAAs much more affordable than the original launch prices. Discuss specific costs and access pathways with your doctor.
After Successful Treatment
Once hepatitis C is cured, what comes next:
Liver healing.
After the virus is eliminated, the liver typically begins healing. Mild inflammation resolves quickly. Fibrosis can partially reverse over time, especially if cirrhosis hasn’t developed. Liver function tests typically normalise.
Long-term monitoring.
Patients who had advanced fibrosis or cirrhosis at the time of treatment continue to need monitoring (typically every 6-12 months) for liver cancer screening, even after cure. The cancer risk is reduced after cure but not eliminated for those who already had significant liver damage.
Re-infection is possible.
Cure doesn’t grant immunity. If you’re exposed to hepatitis C again after successful treatment, you can become infected again. Safe practices remain important, particularly for people with ongoing exposure risks.
Lifestyle factors that help liver recovery.
Alcohol cessation or reduction is the single most impactful lifestyle change. Maintaining healthy weight, managing diabetes if present, and avoiding hepatotoxic medications without medical guidance all support liver health.
A Patient Conversation Worth Sharing
A 52-year-old patient came to our clinic last year for routine pre-employment medical (he was changing jobs and the new role required updated medicals). His tests included hepatitis C antibody — positive. Subsequent RNA testing confirmed active chronic infection.
He had no symptoms. He had no obvious risk factors that came to mind. Looking back at his medical history, he’d had a blood transfusion in 1988 after a road accident in his early teens — long before universal donor screening for hepatitis C was implemented in Malaysia. He had probably been infected for over 30 years without knowing.
His liver tests showed moderate fibrosis but not cirrhosis — significant damage but not yet at the dangerous stage. He started a 12-week course of DAA treatment. Took the pills, had minimal side effects, completed the course. Twelve weeks after finishing treatment: virus undetectable. Six months later: still undetectable, liver function tests normalising.
“If I hadn’t taken that job and that medical, I would have just kept going until something broke,” he told us at his follow-up. “I had no idea this was happening.”
The Public Health Aspiration
The World Health Organization has set a global goal of eliminating hepatitis C as a public health threat by 2030. The means to achieve this exist — testing is cheap, treatment is effective, the cure is real. The bottleneck is connecting people with both.
On an individual level, this means a few things. If you’ve never been tested for hepatitis C, getting tested once is a remarkably high-value medical investment. The test costs little. If you’re negative, you have peace of mind. If you’re positive, you have access to a curable condition that would have otherwise damaged your liver over decades.
If you’re under 40 and have no clear risk factors, your statistical probability of having hepatitis C is low — but not zero. If you’re older or have any risk factors at all, the probability is meaningfully higher. Either way, one-time testing is worth doing.
Get Tested at Dr Prevents
Hepatitis C testing is part of the comprehensive STI panels we offer at Dr Prevents in our KL and Selangor clinics. The blood test is straightforward, results return within 1 to 5 working days, and the whole process is fully confidential.
If you’ve never been tested, please come in. Most patients leave with negative results and one less thing to wonder about. The minority who test positive benefit from one of the genuine medical success stories of the past decade — a curable condition with treatment that has dramatically transformed outcomes. Either way, knowing your status is a small investment with potentially significant return.
📞 Curable. Findable. Worth doing once. Walk in today. 🩺